FDA Panel Recommends Moderna’s COVID-19 Vaccine, the Second To Receive Such Approval in the U.S.

FDA Panel Recommends Moderna’s COVID-19 Vaccine, the Second To Receive Such Approval in the U.S.

TIME

Published